Verve Therapeutics Statistics
Total Valuation
NGX:NPFMCRFBK has a market cap or net worth of NGN 18.46 billion.
Market Cap | 18.46B |
Enterprise Value | n/a |
Important Dates
The last earnings date was Tuesday, July 29, 2025.
Earnings Date | Jul 29, 2025 |
Ex-Dividend Date | May 29, 2025 |
Share Statistics
NGX:NPFMCRFBK has 5.99 billion shares outstanding. The number of shares has decreased by -2.00% in one year.
Current Share Class | 5.99B |
Shares Outstanding | 5.99B |
Shares Change (YoY) | -2.00% |
Shares Change (QoQ) | -1.64% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 6.77.
PE Ratio | 6.77 |
Forward PE | n/a |
PS Ratio | 1.20 |
PB Ratio | 1.43 |
P/TBV Ratio | 1.43 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -0.03 |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 23.49M |
Profits Per Employee | 4.15M |
Employee Count | 655 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, NGX:NPFMCRFBK has paid 1.63 billion in taxes.
Income Tax | 1.63B |
Effective Tax Rate | 37.53% |
Stock Price Statistics
The stock price has increased by +83.33% in the last 52 weeks. The beta is 0.28, so NGX:NPFMCRFBK's price volatility has been lower than the market average.
Beta (5Y) | 0.28 |
52-Week Price Change | +83.33% |
50-Day Moving Average | 2.37 |
200-Day Moving Average | 1.89 |
Relative Strength Index (RSI) | 65.28 |
Average Volume (20 Days) | 3,628,381 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NGX:NPFMCRFBK had revenue of NGN 15.38 billion and earned 2.72 billion in profits. Earnings per share was 0.46.
Revenue | 15.38B |
Gross Profit | 14.85B |
Operating Income | 4.35B |
Pretax Income | 4.35B |
Net Income | 2.72B |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | 0.46 |
Balance Sheet
The company has 9.82 billion in cash and 327.17 million in debt, giving a net cash position of 9.50 billion or 1.58 per share.
Cash & Cash Equivalents | 9.82B |
Total Debt | 327.17M |
Net Cash | 9.50B |
Net Cash Per Share | 1.58 |
Equity (Book Value) | 12.90B |
Book Value Per Share | 2.15 |
Working Capital | 11.66B |
Cash Flow
In the last 12 months, operating cash flow was -9.95 billion and capital expenditures -565.50 million, giving a free cash flow of -10.51 billion.
Operating Cash Flow | -9.95B |
Capital Expenditures | -565.50M |
Free Cash Flow | -10.51B |
FCF Per Share | -1.75 |
Margins
Gross Margin | n/a |
Operating Margin | 28.25% |
Pretax Margin | 28.26% |
Profit Margin | 17.65% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 4.87%.
Dividend Per Share | 0.15 |
Dividend Yield | 4.87% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | 59.59% |
Buyback Yield | 2.00% |
Shareholder Yield | 6.87% |
Earnings Yield | 14.71% |
FCF Yield | -56.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on May 30, 2022. It was a forward split with a ratio of 1.1111111111.
Last Split Date | May 30, 2022 |
Split Type | Forward |
Split Ratio | 1.1111111111 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |